G. D. Wright, Molecular mechanisms of antibiotic resistance, Chem. Commun, vol.47, pp.4055-4061, 2011.

J. Lin, N. Nishino, M. C. Roberts, M. Tolmasky, R. I. Aminov et al., Mechanisms of antibiotic resistance, Front. Microbiol, vol.6, pp.1-3, 2015.

S. D?idi?, J. ?u?kovi?, and B. Kos, Antibiotic resistance mechanisms in bacteria: biochemical and genetic aspects, Food Technol. Biotechnol, vol.46, pp.11-21, 2008.

H. Nicaido and H. Zgurskaya, Antibiotic efflux mechanism, Curr. Opin. Infect. Dis, vol.12, pp.529-536, 1999.

M. Webber and L. Piddock, The importance of efflux pumps in bacterial antibiotic resistance, J. Antimicrob. Chemother, vol.51, pp.9-11, 2003.

H. Van-veen and W. Konings, Drug efflux proteins in multidrug resistant bacteria, Biol. Chem, vol.378, pp.769-777, 1997.

G. Cox and G. D. Wright, Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions, Int. J. Med. Microbiol, vol.303, pp.287-292, 2013.

L. J. Piddock, Multidrug-resistance efflux pumps? not just for resistance, Nat. Rev. Microbiol, vol.4, pp.629-636, 2006.

I. T. Paulsen, M. H. Brown, and R. A. Skurray, Proton-dependent multidrug efflux systems, Microbiol. Rev, vol.60, pp.575-608, 1996.

G. D. Wright, The antibiotic resistome: the nexus of chemical and genetic diversity, Nat. Rev. Microbiol, vol.5, pp.175-186, 2007.

C. Mims, H. M. Dockrell, R. V. Goering, I. Roitt, D. Wakelin et al., Attacking the Enemy: Antimicrobial Agents and Chemotherapy: Macrolides, Medical Microbiology, p.489, 2004.

C. Walsh, Molecular mechanisms that confer antibacterial drug resistance, Nature, vol.406, pp.775-781, 2000.

G. Kapoor, S. Saigal, and A. Elongavan, Action and resistance mechanisms of antibiotics: A guide for clinicians, J. Anaesthesiol. Clin. Pharmacol, vol.33, pp.300-305, 2017.

A. Philippon, G. Arlet, and G. A. Jacoby, Plasmid-determined AmpC-type ?-lactamases

, Antimicrob. Agents Chemother, vol.46, pp.1-11, 2002.

P. A. Bradford, Extended-spectrum ?-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat, Clin. Microbiol. Rev, vol.14, pp.933-951, 2001.

A. Shah, F. Hasan, S. Ahmed, and A. Hameed, Extended-spectrum ?-lactamases (ESBLs): characterization, epidemiology and detection, Crit. Rev. Microbiol, vol.30, pp.25-32, 2004.

A. Giedraitien?, A. Vitkauskien?, R. Naginien?, and A. Pavilonis, Antibiotic resistance mechanisms of clinically important bacteria, vol.47, pp.137-146, 2011.

M. N. Alekshun and S. B. Levy, Molecular mechanisms of antibacterial multidrug resistance, Cell, vol.128, pp.1037-1050, 2007.

D. Greenwood, , 2007.

M. Khoder, N. Tsapis, and E. Fattal, Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence, J. Drug Deliv. Sci. Technol, vol.20, pp.407-418, 2010.

A. Alonso, E. Campanario, and J. L. Mart??ez, Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa, Microbiology, vol.145, pp.2857-286, 1999.

P. M. Hawkey, The origins and molecular basis of antibiotic resistance, Br. Med. J, vol.317, pp.657-660, 1998.

P. Courvalin, Predictable and unpredictable evolution of antibiotic resistance, J. Intern. Med, vol.264, pp.4-16, 2008.

S. B. Levy and B. Marshall, Antibacterial resistance worldwide: causes, challenges and responses, Nat. Med, vol.10, pp.122-129, 2004.

P. Bennett, Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria, Br. J. Pharmacol, vol.153, pp.347-357, 2008.

B. R. Lyon and R. Skurray, Antimicrobial resistance of Staphylococcus aureus: genetic basis, Microbiol. Rev, vol.51, pp.88-134, 1987.

R. Domalaon, T. Idowu, G. G. Zhanel, and F. Schweizer, Antibiotic hybrids: the next generation of agents and adjuvants against Gram-negative pathogens?, Clin. Microbiol. Rev, vol.31, pp.77-94, 2018.

G. Eliopoulos and C. Eliopoulos, Antibiotic combinations: should they be tested?, Clin. Microbiol. Rev, vol.1, pp.139-156, 1988.

G. D. Wright, Antibiotic adjuvants: rescuing antibiotics from resistance, Trends Microbiol, vol.24, pp.862-871, 2016.

B. D. Brooks and A. E. Brooks, Therapeutic strategies to combat antibiotic resistance, Adv. Drug Del. Rev, vol.78, pp.14-27, 2014.

C. González-bello, Antibiotic adjuvants-A strategy to unlock bacterial resistance to antibiotics, Bioorg. Med. Chem. Lett, vol.27, pp.4221-4228, 2017.

L. Kalan and G. D. Wright, Antibiotic adjuvants: multicomponent anti-infective strategies, Expert Rev. Mol. Med, 2011.

S. Chakradhar, Reservoirs of resistance: To understand why antibiotics fail, geneticists chase the 'resistome', Nat. Med, vol.22, pp.1069-1071, 2016.

R. J. Melander and C. Melander, The challenge of overcoming antibiotic resistance: an adjuvant approach? ACS infectious diseases, vol.3, pp.559-563, 2017.

M. Martins, S. G. Dastigar, S. Fanning, J. E. Kristiansen, J. Molnar et al., Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities, Int. J. Antimicrob. Agents, vol.31, pp.198-208, 2008.

J. E. Kristiansen and L. Amaral, The potential management of resistant infections with nonantibiotics, The Journal of antimicrobial chemotherapy, vol.40, pp.319-327, 1997.

L. Amaral and V. Lorian, Effects of chlorpromazine on the cell envelope proteins of Escherichia coli, Antimicrob. Agents Chemother, vol.35, pp.1923-1924, 1991.

N. K. Dutta, S. Annadurai, K. Mazumdar, S. G. Dastidar, J. E. Kristiansen et al., Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium, Int. J. Antimicrob. Agents, vol.30, pp.242-249, 2007.

L. Amaral, M. Martins, and M. Viveiros, Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps, J. Antimicrob. Chemother, vol.59, pp.1237-1246, 2007.

K. Bush, Beta-lactamase inhibitors from laboratory to clinic, Clin. Microbiol. Rev, vol.1, pp.109-123, 1988.

M. G. Page and . ?-lactamase-inhibitors, Drug Resistance Updates, vol.3, pp.109-125, 2000.

J. D. Williams, ?-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone, Clin. Infect. Dis, vol.24, pp.494-497, 1997.

D. M. Shlaes, New ?-lactam-?-lactamase inhibitor combinations in clinical development

, Ann. N.Y. Acad. Sci, vol.1277, pp.105-114, 2013.

A. R. White, C. Kaye, J. Poupard, R. Pypstra, G. Woodnutt et al., Augmentin (amoxicillin/clavulanate) in the treatment of communityacquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent, J. Antimicrob. Chemother, vol.53, pp.3-20, 2004.

S. M. Drawz and R. A. Bonomo, Three decades of beta-lactamase inhibitors, Clin. Microbiol. Rev, vol.23, pp.160-201, 2010.

M. Gniadkowski, Evolution and epidemiology of extendedspectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms, Clin. Microbiol. Infect, vol.7, pp.597-608, 2001.

D. L. Paterson and R. A. Bonomo, Extended-spectrum beta-lactamases: a clinical update, Clin. Microbiol. Rev, vol.18, pp.657-686, 2005.

G. D. Wright, Antibiotic adjuvants: rescuing antibiotics from resistance, Trends Microbiol, vol.24, pp.862-871, 2016.

E. E. Gill, O. L. Franco, and R. E. Hancock, Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des, vol.85, pp.56-78, 2015.

M. Pieren and M. Tigges, Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance, Curr. Opin. Pharmacol, vol.12, pp.551-555, 2012.

L. Kalan and G. D. Wright, Antibiotic adjuvants: multicomponent antiinfective strategies, Expert Rev. Mol. Med, 2011.

T. W. Yenn, M. ;-arslan-khan, N. Amiera-syuhada, L. Chean-ring, D. Ibrahim et al., Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates, vol.128, pp.68-71, 2017.

A. R. English, J. A. Retsema, A. E. Girard, J. E. Lynch, and W. E. Barth, CP-45,899, a betalactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization, Antimicrob. Agents Chemother, vol.14, pp.414-419, 1978.

A. Bonnefoy, C. Dupuis-hamelin, V. Steier, C. Delachaume, T. Seys et al., In vitro activity of AVE1330A, an innovative broadspectrum non-?-lactam ?-lactamase inhibitor, J. Antimicrob. Chemother, vol.54, pp.410-417, 2004.

S. T. Cahill, R. Cain, D. Y. Wang, C. T. Lohans, D. W. Wareham et al., Cyclic boronates inhibit all classes of ?-lactamases, Antimicrob. Agents Chemother, vol.61, pp.2260-02216, 2017.

A. M. King, S. A. Reid-yu, W. Wang, D. T. King, G. De-pascale et al., Aspergillomarasmine A overcomes metallobeta-lactamase antibiotic resistance, Nature, vol.510, pp.503-506, 2014.

K. Koteva, A. M. King, A. Capretta, and G. D. Wright, Total synthesis and activity of the metallo-beta-lactamase inhibitor aspergillomarasmine A, Angew. Chem. Int. Ed. Engl, vol.55, pp.2210-2212, 2016.

S. A. Albu, K. Koveta, A. M. King, S. Al-karmi, G. D. Wright et al., Total synthesis of aspergillomarasmine A and related compounds: a sulfamidate approach enables exploration of structure-activity relationships, Angew. Chem. Int. Ed. Engl, vol.55, pp.13259-13262, 2016.

R. F. Jacobs, Imipenem-cilastatin: the first thienamycin antibiotic, Pediatr. Infect. Dis, vol.5, pp.444-448, 1986.

F. Von-nussbaum and G. Schiffer, Aspergillomarasmine A, an Inhibitor of Bacterial Metallo?-Lactamases Conferring blaNDM and blaVIM Resistance, Angew. Chem. Int. Ed. Engl, vol.53, pp.11696-11698, 2014.

T. A. Blizzard, H. Chen, S. Kim, J. Wu, R. Bodner et al., Discovery of MK-7655, a ?-lactamase inhibitor for combination with Primaxin®, Bioorg. Med. Chem. Lett, vol.24, pp.780-785, 2014.

F. Van-bambeke, Y. Glupczynski, P. Plesiat, J. Pechere, and P. M. Tulkens, Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy, J. Antimicrob. Chemother, vol.51, pp.1055-1065, 2003.

G. P-tegos, M. Haynes, J. J. Strousse, M. M. Khan, C. G. Bologa et al.,

A. , Microbial efflux pump inhibition: tactics and strategies, Curr. Pharm. Des, vol.17, pp.1291-1302, 2011.

B. Zechini and I. Versace, Inhibitors of multidrug resistant efflux systems in bacteria, Recent Pat. Antiinfect Drug Discov, vol.4, pp.37-50, 2009.

X. Z. Li and H. Nikaido, Efflux-mediated drug resistance in bacteria, Drugs, vol.64, pp.159-204, 2004.

K. Poole, Efflux-mediated antimicrobial resistance, J. Antimicrob. Chemother, vol.56, pp.20-51, 2005.

Y. C. Fiamegos, P. L. Kastritis, V. Exarchou, H. Han, A. M. Bonvin et al., Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria, PLoS One, vol.6, 2011.

A. Bhardwaj and P. Mohanty, Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy, Recent Pat. Antiinfect Drug Discov, vol.7, pp.73-89, 2012.

J. M. Bolla, S. Alibert-franco, J. Handzlik, J. Chevalier, A. Mahamoud et al., Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01425039

F. Van-bambeke and V. J. Lee, Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux, Recent Pat. Antiinfect Drug Discov, vol.1, pp.157-175, 2006.

L. J. Piddock, Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria, Clin. Microbiol. Rev, vol.19, pp.382-402, 2006.

M. Malléa, A. Mahamoud, J. Chevalier, S. Alibert-franco, P. Brouant et al., Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrugresistant clinical isolates, Biochem. J, vol.376, pp.801-805, 2003.

T. Siriyong, P. Srimanote, S. Chusri, B. E. Yingyongnarongkul, C. Suaisom et al., Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa, BMC Complement. Altern. Med, vol.17, p.405, 2017.

Y. Wang, R. Mowla, L. Guo, A. D. Ogunniyi, T. Rahman et al., Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance, Bioorg. Med. Chem. Lett, vol.27, pp.733-739, 2017.

K. E. Whalen, K. L. Poulson-ellestad, R. W. Deering, D. C. Rowley, and T. J. Mincer, Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3, 4-dibromopyrrole-2, 5-dione isolated from a Pseudoalteromonas sp, J. Nat. Prod, vol.78, pp.402-412, 2015.

R. Kanagaratnam, R. Sheikh, F. Alharbi, and D. H. Kwon, An efflux pump

, of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG), Phytomedicine, vol.36, pp.194-200, 2017.

A. H. Delcour, Outer membrane permeability and antibiotic resistance, Biochim. Biophys. Acta, vol.1794, pp.808-816, 2009.

H. Nikaido, Molecular basis of bacterial outer membrane permeability revisited. Microbiol, Mol. Biol. Rev, vol.67, pp.593-656, 2003.

M. Zahn, S. P. Bhamidimarri, A. Baslé, M. Winterhalter, . Van-den et al., Structural insights into outer membrane permeability of Acinetobacter baumannii, Structure, vol.24, pp.221-231, 2016.

J. M. Bolla, S. Alibert-franco, J. Handzlik, J. Chevalier, A. Mahamoud et al., Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria, FEBS Lett, vol.585, pp.1682-1690, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01425039

J. G. Hurdle, A. J. O'neill, I. Chopra, and R. E. Lee, Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections, Nat. Rev. Microbiol, vol.9, pp.62-75, 2011.

S. Vooturi and S. Firestine, Synthetic membrane-targeted antibiotics, Curr. Med. Chem, vol.17, pp.2292-2300, 2010.

M. E. Falagas, P. I. Rafailidis, and D. K. Matthaiou, Resistance to polymyxins: mechanisms, frequency and treatment options. Drug resistance updates, vol.13, pp.132-138, 2010.

M. Vaara, Polymyxins and their novel derivatives, Curr. Opin. Microbiol, vol.13, pp.574-581, 2010.

Y. Li, X. Sun, J. Feng, and H. Mo, Antibacterial activities and membrane permeability actions of glycinin basic peptide against Escherichia coli, Innov. Food Sci. Emerg. Technol, vol.31, pp.170-176, 2015.

J. C. Andrade, M. F. Morais-braga, G. M. Guedes, S. R. Tintino, M. A. Freitas et al., Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism, Saudi J. Biol. Sci, vol.24, pp.59-64, 2017.

S. Chusri, P. Na-phatthalung, T. Siriyong, S. Paosen, and S. P. Voravuthikunchai,

, Holarrhena antidysenterica as a resistance modifying agent against Acinetobacter baumannii: its effects on bacterial outer membrane permeability and efflux pumps, Microbiol. Res, vol.169, pp.417-424, 2014.

E. Guaní-guerra, T. Santos-mendoza, S. O. Lugo-reyes, and L. M. Terán, Antimicrobial peptides: general overview and clinical implications in human health and disease, Clin. Immunol, vol.135, pp.1-11, 2010.

M. Seil, C. Nagant, J. Dehaye, M. Vandenbranden, and M. F. Lensink, Spotlight on human LL-37, an immunomodulatory peptide with promising cell-penetrating properties, Pharmaceuticals, vol.3, pp.3435-3460, 2010.

B. Ding, U. Taotofa, T. Orsak, M. Chadwell, and P. B. Savage, Synthesis and Characterization of Peptide? Cationic Steroid Antibiotic Conjugates, Org. Lett, vol.6, pp.3433-3436, 2004.

F. Van-bambeke, M. Mingeot-leclercq, M. J. Struelens, and P. M. Tulkens, The bacterial envelope as a target for novel anti-MRSA antibiotics, Trends Pharmacol. Sci, vol.29, pp.124-134, 2008.

X. Lai, Y. Feng, J. Pollard, J. N. Chin, M. J. Rybak et al., Ceragenins: cholic acid-based mimics of antimicrobial peptides, Acc. Chem. Res, vol.41, pp.1233-1240, 2008.

H. Jenssen, P. Hamill, and R. E. Hancock, Peptide antimicrobial agents, Clin. Microbiol. Rev, vol.19, pp.491-511, 2006.

R. Bals and J. Wilson, Cathelicidins-a family of multifunctional antimicrobial peptides, Cell

C. Li, A. S. Peters, E. L. Meredith, G. W. Allman, and P. B. Savage, Design and synthesis of potent sensitizers of Gram-negative bacteria based on a cholic acid scaffolding, J. Am. Chem. Soc, vol.120, pp.2961-2962, 1998.

R. M. Epand, R. F. Epand, and P. B. Savage, Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents, Drug News Perspect, vol.21, pp.307-311, 2008.

U. Surel, K. Niemirowicz, M. Marzec, P. B. Savage, and R. Bucki, Ceragenins-a new weapon to fight multidrug resistant bacterial infections, Medical Studies, vol.30, pp.207-213, 2014.

B. Ding, Q. Guan, J. P. Walsh, S. Boswell, T. W. Winter et al., Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics, J. Med. Chem, vol.45, pp.663-669, 2002.

K. Kikuchi, E. M. Bernard, A. Sadownik, S. L. Regen, and D. Armstrong, Antimicrobial activities of squalamine mimics, Antimicrob. Agents Chemother, vol.41, pp.1433-1438, 1997.

C. Li, M. R. Lewis, A. B. Gilbert, M. D. Noel, D. H. Scoville et al., Antimicrobial activities of amine-and guanidine-functionalized cholic acid derivatives, Antimicrob. Agents Chemother, vol.43, pp.1347-1349, 1999.

C. Li, L. P. Budge, C. D. Driscoll, B. M. Willardson, G. W. Allman et al., Incremental conversion of outer-membrane permeabilizers into potent antibiotics for Gramnegative bacteria, J. Am. Chem. Soc, vol.121, pp.931-940, 1999.

J. N. Chin, M. J. Rybak, C. M. Cheung, and P. B. Savage, Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus, Antimicrob. Agents Chemother, vol.51, pp.1268-1273, 2007.

C. Bozkurt-guzel, P. B. Savage, A. Akcali, and B. Ozbek-celik, Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients, BioMed Res. Int, p.710273, 2014.

K. Yasuda, C. Ohmizo, and T. Katsu, Mode of action of novel polyamines increasing the permeability of bacterial outer membrane, Int. J. Antimicrob. Agents, vol.24, pp.67-71, 2004.

T. Katsu, H. Nakagawa, and K. Yasuda, Interaction between polyamines and bacterial outer membranes as investigated with ion-selective electrodes, Antimicrob. Agents Chemother, vol.46, pp.1073-1079, 2002.

M. Vaara, Agents that increase the permeability of the outer membrane, Microbiol. Rev, vol.56, pp.395-411, 1992.

H. Nikaido, Outer membrane, Escherichia coli and Salmonella. Cell. Mol. Biol, pp.29-47, 1996.

K. Yasuda, C. Ohmizo, and T. Katsu, Potassium and tetraphenylphosphonium ion-selective electrodes for monitoring changes in the permeability of bacterial outer and cytoplasmic membranes, J. Microbiol. Methods, vol.54, pp.111-115, 2003.

C. Salmi, C. Loncle, N. Vidal, Y. Letourneux, J. Fantini et al., Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?, PLoS One, vol.3, p.2765, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00400776

J. Lavigne, J. M. Brunel, J. Chevalier, and J. M. Pagès, Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria, J. Antimicrob. Chemother, vol.65, pp.799-801, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00465656

M. Blanchet, D. Borselli, A. Rodallec, F. Peiretti, N. Vidal et al., Claramines: A new class of broad-spectrum antimicrobial agents with bimodal activity, ChemMedChem, vol.13, pp.1018-1027, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02110834

D. Borselli, M. Blanchet, J. M. Bolla, A. Muth, K. Skruber et al., Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria, vol.18, pp.276-283, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01789352

C. Pieri, D. Borselli, C. Di-giorgio, M. De-méo, J. M. Bolla et al., New Ianthelliformisamine derivatives as antibiotic enhancers against resistant Gram-negative bacteria, J. Med. Chem, vol.57, pp.4263-4272, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01460535

J. M. Brunel, A. Lieutaud, V. Lome, J. M. Pagès, and J. Bolla, Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant Gram-negative bacteria, Biorg. Med. Chem, vol.21, pp.1174-1179, 2013.

D. Borselli, A. Lieutaud, H. Thefenne, E. Garnotel, J. M. Pagès et al., Polyamino-isoprenic derivatives block intrinsic resistance of P. aeruginosa to doxycycline and chloramphenicol in vitro, PLoS One, vol.11, p.154490, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01463102